Management Team
Management Team
PathoQuest’s management team has significant experience and expertise with in vitro diagnostics and the development, validation and commercialization of metagenomic solutions for the identification of pathogens.
Jean-Francois Brepson – President and CEO
Jean-Francois Brepson – President and CEO
Jean-François Brepson has over 20 years of leadership experience in the Pharmaceutical Industry. Prior to joining PathoQuest, Mr. Brepson was a Senior Vice-President at IPSEN where he was responsible for leading the global GI-Oncology & Endocrinology Franchise. Mr. Brepson has an Engineering Degree in Data Management System and a Master’s degree in Foreign Trade. He has also earned “The Leadership & Innovation Certificate” for HEC in Paris and “The Blue Ocean Strategy Certificate” from INSEAD in Fontainebleau-France. →
Colette Côté, Ph.D. – CPO & US General Manager
Colette Côté, Ph.D. – CPO & General Manager
Dr. Côté has nearly 20 years of experience in industry with a focus on applying & expanding the use of NGS in the biosafety testing field. She recently was Head of NGS R&D Testing Services at MilliporeSigma, a well-known stakeholder of the biosafety testing and viral vector manufacturing industry. She started her career as a Senior Scientist at Intronn Inc, and then moved to Innovative Biosensors Inc where she developed and engineered biosensors for rapid biodefense and clinical pathogen detection. Colette received her Ph.D. in Molecular Biology, Cell Biology, and Biochemistry from the Brown University and completed her postdoctoral fellowship in the Genetics and Biochemistry Branch at the NIH. She contributed to various papers, publications, and patents throughout her career. →
Eric Cazergue, MBA – Chief Financial Officer
Eric Cazergue, MBA – Chief Financial Officer
Prior to joining us, Mr. Cazergue was Finance & Operations Director at Corin France with responsibilities for coordinating the support functions in a post-acquisition and business recovery environment. Before, he was VP of Finance for EMEA APAC at Resmed, a medical device company. Previous to the above, he was CFO at Sanofi Aventis Turkey where he supported the company’s strong business growth and organizational development. He also was also a key contributor to the local merger process of Rhone Poulenc/HMR and between Sanofi/Aventis. Eric Cazergue holds a Master of Business Administration (MBA) from Emlyon Business School (EM Lyon) in Lyon, France, and a Master’s in Finance and Accounting from the University of Lyon →
Christine Dangles, eMBA – Chief Human Resources and Facility Officer
Christine Dangles, eMBA – Chief Human Resources and Facility Officer
Ms. Christine Dangles joined PathoQuest in 2017. Her professional experiences include responsibilities for executive-level management, employee training and development, organizational development, and employee relations. She has worked across a diverse range of industries, including the pharmaceutical and food industry. Ms. Dangles has significant international insight and diversity understanding based on 15 years abroad, Russia, the United States, and South America. Ms. Dangles has a degree in Human Resources & Transformation Business Administration and Management and is a certified professional coach from the Haute Ecole de Coaching Paris-France. →
Guillaume Deplaine, Ph.D., Head of Operations
Guillaume Deplaine, Ph.D., Head of Operations
Dr. Guillaume Deplaine has 10 years of experience in the Biotechnology industry. Prior to joining PathoQuest, Dr. Deplaine was the Quality Control and Analytical Development Head at CELLforCURE a CDMO specialized in CART Cells manufacturing, and was part of the Novartis Group. Before, he was Quality Control Head at THERAVECTYS, a company based on lentiviral technology to develop vaccines. Previous to the above, he was Project manager for medical devices in the genetic diagnosis field. Dr. Deplaine is graduated from the University of Pierre et Marie CURIE/Pasteur Institute and holds a Ph.D in Molecular & Cell Biology. He is co-author of several publications and patents. →
Pascale Beurdeley, Ph.D. – Chief Scientific Officer
Pascale Beurdeley, Ph.D. – Chief Scientific Officer
Dr. Pascale Beurdeley has 18 years’ experience in the biotechnology industry. Prior to joining PathoQuest, Dr. Beurdeley was the Executive Director R&D, Genomics at DiaxonHit (formerly ExonHit Therapeutics) where she contributed to the development and the promotion of the company’s proprietary platform for the analysis of gene expression and alternative splicing. Dr. Beurdeley is graduated from the University Louis Pasteur Strasbourg-France and holds a Ph. D in Molecular & Cell Biology. She completed her post-doctoral fellow at Magainin Pharmaceuticals Inc- USA. →
Stéphane Cruveiller, Ph.D. – Chief Technology Information Officer
Stéphane Cruveiller, Ph.D. – Chief Technology Information Officer
Dr. Stéphane Cruveiller has more than 20 years of experience in bioinformatics applied to genomics and is (co-)author of nearly 80 publications. Prior to joining PathoQuest, Dr. Cruveiller was head of a team at the Bioinformatics Analysis Laboratory for Genomics and Metabolism of the Institut de biologie François Jacob (Commissariat à l’énergie atomique et aux énergies alternatives). Dr. Cruveiller is a graduate of the University of Paris VII and holds a PhD in genome analysis and molecular modeling. He completed his post-doctoral training at the Stazione Zoologica Anton Dohrn in Naples, Italy, where he contributed to important discoveries concerning the evolution of the vertebrate genome. →
Sébastien Renouf, Pharm D., Chief Pharmaceutical Officer, Qualified person
Sébastien Renouf, Pharm D., Chief Pharmaceutical Officer, Qualified person
Dr. Sébastien Renouf has 20 years of experience in Regulatory Affairs, Quality Assurance, and Safety Control for Cell & Gene Therapy. Before joining PathoQuest, Dr. Renouf was Chief Pharmaceutical Officer at CELLforCURE a CDMO specialized in the CART Cells manufacturing and part of the Novartis Group, where he supported the implementation of inspection and marketing authorization accreditation processes. Dr. Renouf has a Pharmacy degree from Paris XI University and is a Therapeutic Biotechnology graduate from Paris VII University and an internship of the Ile-de-France region with an Industrial and Biomedical Pharmacy specialty. →
LET’S START SOMETHING NEW
WELCOME TO PATHOQUEST!